Health Catalyst, Inc. cash flow to debt ratio of 0.43% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Health Catalyst, Inc.'s free cash flow has increased -87.11% from $-1.84M last year to $-237.00K, signaling increasing performance

Health Catalyst, Inc.'s debt to equity ratio is 1.23, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Health Catalyst, Inc.'s debt has increased relative to shareholder equity from 1.10 last year to 1.23 today, signaling weakened financials

Health Catalyst, Inc. has negative EBITDA, making leverage ratio unreliable

Health Catalyst, Inc.'s interest coverage ratio is -2.68, which means that the company struggles to meet interest obligations, signaling financial risk.

Health Catalyst, Inc.'s profit margin has decreased (286.83%) in the last year from -22.67% to -87.69%, signaling decreasing performance

Health Catalyst, Inc.'s short-term assets of $169.31M exceed its short-term liabilities of $89.57M

Health Catalyst, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Health Catalyst, Inc.'s return on equity of -99.78%, is lower than 15.00%, indicating bad performance

Health Catalyst, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Health Catalyst, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Health Catalyst, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Health Catalyst, Inc. has negative free cash flow, indicating cash burn

Health Catalyst, Inc.'s yearly earnings has decreased 156.07% since last year from $-69.50M to $-177.97M, signaling decreasing performance

Health Catalyst, Inc.'s yearly revenue has increased 1.48% since last year from $306.58M to $311.14M, signaling increasing performance

ROIC -18.74% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Health Catalyst, Inc.'s 3-year revenue CAGR of 4.05% is positive, indicating growing revenue over the past 3 years

Health Catalyst, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Health Catalyst, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Health Catalyst, Inc. has insufficient data to evaluate this check.

Health Catalyst, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Health Catalyst, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Health Catalyst, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Health Catalyst, Inc. is overvalued relative to its fair value price of -36.94 based on Earnings Fair Value model

Health Catalyst, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Health Catalyst, Inc. has a price-to-book ratio of 1.20x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Health Catalyst, Inc. has a price-to-sales ratio of 0.55x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue